Abstract
SINCE its introduction by Cerletti and Bini1 in 1938, electroshock therapy has become an accepted therapeutic procedure and has replaced metrazol as the most effective therapeutic convulsive agent. It has been found most useful in depressive states of a manic depressive nature, involutional depressions and involutional paranoid conditions and in depressions of later life and also as an adjunct in the treatment of psychoneuroses with depressive coloring. It has replaced insulin in the treatment of some early cases of schizophrenia, and has been used experimentally in a large variety of neuropsychiatric conditions including general paresis,2 Parkinson's disease,3 tics,3 stammering,4 drug . . .
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
